Brief: Anebulo Pharmaceuticals Reports Q4 Loss Per Share Of $1.59
22/09/2021 21:11
Sept 22 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O :
* ANEBULO PHARMACEUTICALS REPORTS FOURTH QUARTER AND FISCAL
YEAR
2021 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE
* Q4 LOSS PER SHARE $1.59
Source text for Eikon: ID:nBwbLGWTa
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results